To safeguard the future health of healthy individuals and assist disease patients in recovering their health

promote regenerative medicine The clinical translation technology benefits the general public

The company has internationally advanced professional equipment, meets international standards for cell quality control system, and has mastered second-generation adult stem cell technology; Third generation immune cell technology; Third generation stem cell technology (iPS). As a new technology research and development platform, we are currently jointly applying for clinical trials of immune cell/stem cell diseases with the first batch of hospitals with clinical trial qualifications.